We want to see each person treated with the dignity and respect that they deserve.
Joe Pitts
The Public Record
Joseph R. Pitts is a former Republican member of the U.S. House of Representatives, serving Pennsylvania's 16th congressional district from 1997 to 2017. During his tenure, Pitts was known for his focus on healthcare, energy, and family issues, often advocating for conservative policies. He played a significant role in various legislative efforts, including those related to the Affordable Care Act and energy independence. Pitts was also involved with the Pennsylvania Family Institute, reflecting his commitment to family values and social issues.
I stand ready to work with anyone on any of these options to start addressing this crisis because I think I simply can't, I just don't think we can afford to wait any longer.
Unfortunately, too few Americans are currently prepared to pay for even a modest amount of long-term care whether through insurance or savings.
I believe Congress and the Administration have a moral responsibility and duty to solve the problems before they fail the millions of people who depend on them.
We have opened an investigation in the Office of Civil Rights at HHS to investigate. We take this seriously.
This is in direct violation of federal law under the Weldon amendment and a direct assault on conscience rights.
This action by California is a direct violation of the Weldon amendment, which your Department is tasked with enforcing.
The bill before us today takes an important step in protecting our nation's small businesses from unnecessary costs and regulatory burdens. The Common Sense Nutrition Disclosure Act provides for flexibility for the food service industry to…
The Chair thanks the gentlelady. That concludes the questions that we have here. We have follow-up questions. We will submit those to you in writing. We ask that you please respond promptly.
Biologics are used to treat a number of serious diseases and conditions and have improved the lives of millions of Americans.
I supported the creation of a pathway for biosimilars, and for empowering FDA with the authority and resources to ensure that biosimilars are safely available here in the U.S. for the patients that need them the most.
In 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11.
I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into one average sales price calculation and payment code.
FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second application.
I thank the chairman. Mr. Speaker, I rise today in support of the millions of families across the country who have had their health insurance disrupted by the President's health law and in support of the millions more Americans who don't…
The most ancient Christian communities of all are in the Middle East where faith has been handed down in unbroken succession since the Apostles. It is there that terrorists are attempting to commit genocide against Christian believers. To…
I urge my colleagues to support both of these amendments and the underlying resolution.
I would like to reiterate the important work that the National Marrow Donor Program does for patients. Be The Match, operated by the National Marrow Donor Program, has facilitated more than 68,000 marrow and cord blood transplants, which…
I urge all Members to support this important bipartisan, bicameral legislation. Mr. Speaker, I yield back the balance of my time.
I am pleased to yield 1 minute to the gentleman from West Virginia (Mr. Jenkins), a leader on this issue.
I encourage my colleagues to support this commonsense, bipartisan bill. I yield back the balance of my time.





